These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12557287)

  • 1. Plasticity of the nigropallidal pathway in Parkinson's disease.
    Whone AL; Moore RY; Piccini PP; Brooks DJ
    Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
    Rajput AH; Sitte HH; Rajput A; Fenton ME; Pifl C; Hornykiewicz O
    Neurology; 2008 Apr; 70(16 Pt 2):1403-10. PubMed ID: 18172064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in neuronal firing rates in pallidal and cerebellar receiving areas of thalamus in patients with Parkinson's disease, essential tremor, and pain.
    Molnar GF; Pilliar A; Lozano AM; Dostrovsky JO
    J Neurophysiol; 2005 Jun; 93(6):3094-101. PubMed ID: 15703231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease.
    Tang JK; Moro E; Mahant N; Hutchison WD; Lang AE; Lozano AM; Dostrovsky JO
    J Neurophysiol; 2007 Aug; 98(2):720-9. PubMed ID: 17537900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.
    Parent A; Lavoie B; Smith Y; Bédard P
    Adv Neurol; 1990; 53():111-6. PubMed ID: 1978512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of apomorphine on globus pallidus neurons in parkinsonian patients.
    Hutchinson WD; Levy R; Dostrovsky JO; Lozano AM; Lang AE
    Ann Neurol; 1997 Nov; 42(5):767-75. PubMed ID: 9392576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuronal activities in the ventrolateral thalamus and basal ganglia in relation to Parkinson's disease].
    Wang J; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1021-6. PubMed ID: 16784702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models.
    Zold CL; Larramendy C; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 Sep; 26(5):1267-79. PubMed ID: 17767504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.
    Cho SS; Christopher L; Koshimori Y; Li C; Lang AE; Houle S; Strafella AP
    Neurobiol Dis; 2019 Apr; 124():176-182. PubMed ID: 30471418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease.
    Palmer SJ; Li J; Wang ZJ; McKeown MJ
    Neuroscience; 2010 Apr; 166(4):1110-8. PubMed ID: 20074617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute stimulation in the external segment of the globus pallidus improves parkinsonian motor signs.
    Vitek JL; Hashimoto T; Peoples J; DeLong MR; Bakay RA
    Mov Disord; 2004 Aug; 19(8):907-15. PubMed ID: 15300655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal activity in the globus pallidus of multiple system atrophy patients.
    Pereira LC; Palter VN; Lang AE; Hutchison WD; Lozano AM; Dostrovsky JO
    Mov Disord; 2004 Dec; 19(12):1485-92. PubMed ID: 15390066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
    Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
    Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity and function of neurons in the globus pallidus in Parkinson's disease].
    Marković L; Sterio D; Berić A
    Med Pregl; 1996; 49(1-2):11-6. PubMed ID: 8643063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.